ProSomnus Q1 revenue $7.5M (+28% YoY) but files Chapter 11 restructuring

ProSomnus, Inc.

2024-Q1 EPS reported -$0.02 revenue$7,458,000

Q1 revenue $7.5M, up 28% YoY from $5.8M.
Filed Chapter 11 restructuring on May 7; expects $20M new capital, ~60% debt reduction, return to private.
RPMO 2 device expected to begin clinical testing before FDA submission in June 2024.
Customer on-time deliveries above 99%.

item 2.02 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.95

ProSomnus, Inc. reported first quarter ended March 31, 2024 results: revenue $7.5 million.

Period: first quarter ended March 31, 2024
Revenue: $7.5 million
Result: reported results

Exact text from the filing

Revenue for the first quarter of 2024 totaled $7.5 million, an increase of $1.7 million or 28% compared to $5.8 million for the first quarter of 2023

View on SEC.gov

1362 earnings releases filed in the last 30 days. Browse all earnings releases →

Source: SEC EDGAR

accession 0001104659-24-062291

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.